Related Experiment Video
Updated: Jul 25, 2026

08:50
A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative.
J Vandelaer1, M Birmingham, F Gasse
1UNICEF, 5-7 Avenue de la Paix, CH-1202 Geneva, Switzerland.
Vaccine
|July 10, 2003
Summary
Maternal and neonatal tetanus (MNT) can be prevented with vaccines. Supplemental immunization activities targeting women of childbearing age are crucial for MNT elimination, especially in high-risk areas.
Area of Science:
- Public Health
- Vaccinology
- Epidemiology
Background:
- Tetanus remains a significant global health threat, causing substantial mortality, particularly maternal and neonatal tetanus (MNT).
- Neonatal tetanus alone caused an estimated 200,000 deaths in 2000, with 90% concentrated in 27 of 57 priority countries.
- MNT is preventable through maternal immunization during pregnancy.
Purpose of the Study:
- To outline strategies for the elimination of maternal and neonatal tetanus (MNT) by 2005.
- To highlight the importance of immunization for women of childbearing age in achieving MNT elimination goals.
- To describe the "high risk approach" and supplemental immunization activities (SIAs) as key interventions.
Main Methods:
- Implementing clean delivery practices.
- Administering tetanus toxoid (TT) containing vaccines to pregnant women and women of childbearing age in high-risk areas.
- Utilizing supplemental immunization activities (SIAs) to reach underserved populations.
Main Results:
- Supplemental immunization activities (SIAs) have reached approximately 17 million women with at least two doses of TT vaccine in the past three years.
- An estimated 200 million additional women need to be targeted in the coming years.
- SIAs are expected to significantly reduce the burden of MNT.
Conclusions:
- MNT elimination requires a multi-pronged approach including routine immunization, clean delivery practices, and targeted SIAs.
- The "high risk approach" is essential for reaching women in underserved areas.
- Sustained efforts in immunization and clean delivery are necessary to maintain MNT elimination.
Related Concept Videos
Vaccinations
Overview
International Nursing Organizations II
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Tetanus
Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

